pneumovax 23 inj. sol. s.c./i.m. pre-filled syr.
msd belgium bv-srl - pneumococcal polysaccharide vaccine 25 - solution for injection in pre-filled syringe - pneumococcal polysaccharide vaccine, 23-valent - pneumococcus, purified polysaccharides antigen
typhim vi (single dose)
sanofi-aventis (malaysia) sdn. bhd. - purified vi capsular p/s of s.typhi -
typhim vi (20 doses)
sanofi-aventis (malaysia) sdn. bhd. - purified vi capsular p/s of s.typhi -
typhim vi injection 0.025 mg0.5 ml
sanofi-aventis singapore pte. ltd. - purified vi capsular polysaccharide of s.typhi (type 2 strain) - injection - purified vi capsular polysaccharide of s.typhi (type 2 strain) 25 micrograms
menactra solution for injection
sanofi-aventis (malaysia) sdn. bhd. - purified meningococcal polysaccharide group a; purified meningococcal polysaccharide group c; purified meningococcal polysaccharide group y; purified meningococcal polysaccharide group w135 -
pneumovax 23 solution for injection
merck sharp & dohme b.v. waarderweg 39 - pneumococcal polysaccharide vaccine - solution for injection - 25mcg/0,5ml
pneumovax 23 solution for injection
merck sharp & dohme b.v. waarderweg 39 - pneumococcal polysaccharide vaccine - solution for injection - 25mcg/0,5ml
pneumovax 23 solution for injection
merck sharp & dohme b.v. waarderweg 39 - pneumococcal polysaccharide vaccine - solution for injection - 25mcg/0,5ml
nimenrix
pfizer pharmaceuticals israel ltd - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w - 135 polysaccharide; neisseria meningitidis group y polysaccharide - powder and solvent for solution for injection - neisseria meningitidis group y polysaccharide 5 mcg; neisseria meningitidis group w - 135 polysaccharide 5 mcg; neisseria meningitidis group c polysaccharide 5 mcg; neisseria meningitidis group a polysaccharide 5 mcg - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135 and y.
pneumo 23 solution for injection in a pre-filled syringe. polysaccharide pneumococcal vaccine.
sanofi pasteur 14 espace henry vallée , 69007 lyon, france - streptococcus pneumoniae - solution for injection - streptococcus pneumoniae 25 µg - vaccines